Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 7Recruiting 5Active not recruiting 5Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1296Carcinoma, Non-Small-Cell Lung 793Neoplasms 787Colorectal Neoplasms 760Stomach Neoplasms 586Carcinoma, Hepatocellular 581Prostatic Neoplasms 514Lung Neoplasms 465Pancreatic Neoplasms 422Rectal Neoplasms 336Recurrence 312Neoplasm Metastasis 306Leukemia, Myeloid, Acute 293Colonic Neoplasms 283Multiple Myeloma 280Lymphoma 276Esophageal Neoplasms 273Uterine Cervical Neoplasms 272Ovarian Neoplasms 263Melanoma 246Head and Neck Neoplasms 245Precursor Cell Lymphoblastic Leukemia-Lymphoma 210Brain Neoplasms 194Lymphoma, Large B-Cell, Diffuse 186Nasopharyngeal Carcinoma 182Leukemia 173Lymphoma, Non-Hodgkin 171Liver Neoplasms 165Glioblastoma 160Polycystic Ovary Syndrome 157

Interventions

Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Interventional × Adenocarcinoma, Clear Cell × Clear all
NCT00226798 2006-01-04

Immunochemotherapy for Metastatic Renal Cell Carcinoma

Rambam Health Care Campus

Phase 2 Unknown
45 enrolled

Adenocarcinoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡